Articles related to DRUG COSTS

Telemedicine significantly enhances patient access to care by offering a wide range of services from general health to specialized treatments, all at potentially lower costs compared to traditional visits.

Higher telehealth use correlates with increased healthcare utilization and costs, indicating that while telehealth improves access, it may also lead to higher rates of ambulatory care-sensitive hospitalizations.

The Inflation Reduction Act’s out-of-pocket cap on Medicare Part D spending marks a pivotal shift in healthcare economics, potentially altering prescription drug cost dynamics for millions of enrollees. Physicians should be aware of these changes to better support and inform their patients navigating these new financial landscapes.

In an era where specialty drug costs soar, Alternative Funding Programs present a complex solution, balancing cost containment with patient access to essential medications. These programs, while offering potential savings, may also introduce treatment delays and increased financial burdens for patients.

The study’s findings underscore the importance of addressing the high cost of insulin. Despite new products and discounts entering the market, one in four patients still report cost as a barrier to accessing their necessary insulin.

Discover how the Inflation Reduction Act influences pharmaceutical innovation and drug pricing. Learn why delaying drug launches might not be an optimal strategy.